Oliver Lagore Vanvalin Investment Group Myriad Genetics Inc Transaction History
Oliver Lagore Vanvalin Investment Group
- $359 Million
- Q3 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Myriad Genetics Inc stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 220 shares of MYGN stock, worth $3,007. This represents 0.0% of its overall portfolio holdings.
Number of Shares
220
Previous 220
-0.0%
Holding current value
$3,007
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MYGN
# of Institutions
252Shares Held
90.5MCall Options Held
100KPut Options Held
34K-
Black Rock Inc. New York, NY15.2MShares$207 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$141 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.72MShares$91.8 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$70.8 Million0.07% of portfolio
-
State Street Corp Boston, MA4.7MShares$64.3 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.1B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...